Higher Life's Essential 8 scores were associated with a lower presence of lung symptoms and diseases, with risk odds decreasing by 1% to 4% for every 1-point increase in LE8.
Cross-Sectional (n=9,202)
Does a higher Life's Essential 8 score associate with lower incidences of lung diseases and symptoms in the general population?
Higher cardiovascular health as defined by Life's Essential 8 is associated with a lower prevalence of self-reported lung symptoms and diseases.
Effect estimate: 1% to 4% decrease in risk odds per 1-point increase
BACKGROUND: Life's Simple 7 (LS7) has been associated with lung function and chronic obstructive pulmonary disease, and abnormal sleeping increases the risk of cardio-pulmonary diseases and associated comorbidities. We aimed to examine the relation between Life's Essential 8 (LE8), with sleep quality added as the 8th metric to LS7, and lung disease and function. METHODS: In this cross-sectional study, the data from the National Health and Nutrition Examination Survey in 2005-2012 were used, which included 9202 participants. LE8, as a cardiovascular health index, was introduced by the American Heart Association. The outcomes were respiratory symptoms related to chronic bronchitis, asthma, and chronic lung disease. Multivariable logistics and restricted cubic spline regressions were utilized to assess the associations. RESULTS: Approximately 11.53%, 9.60%, 14.94%, 31.82%, 13.02%, 7.06%, and 2.63% of participants self-reported cough, phlegm production, wheezing, exertional dyspnea, asthma, chronic bronchitis, and emphysema, respectively. Participants in the highest category of LE8 had the lowest incidence of lung symptoms and diseases. For every 1-point increase in LE8, the risk odds decreased by 1% to 4% in lung symptoms and diseases. The health behavior score was independently associated with all outcomes, while the health factor score was relevant to wheezing, exertional dyspnea, and asthma. CONCLUSIONS: A higher LE8 score is associated with a lower presence of lung symptoms and diseases. Optimizing LE8 holds a promise for improving clinical outcomes in patients with comorbidities of chronic pulmonary and cardiovascular diseases, a widely recognized modern healthcare challenge.
Bian et al. (Mon,) conducted a cross-sectional in Lung diseases and respiratory symptoms (n=9,202). Life's Essential 8 (LE8) score vs. Lower LE8 score was evaluated on Respiratory symptoms related to chronic bronchitis, asthma, and chronic lung disease (1% to 4% decrease in risk odds per 1-point increase). Higher Life's Essential 8 scores were associated with a lower presence of lung symptoms and diseases, with risk odds decreasing by 1% to 4% for every 1-point increase in LE8.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: